Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Operating activities:
Net loss	$ (2,042,508)	$ (1,477,607)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	202,782	320,672
Amortization of capitalized software development costs	571,428	715,765
Amortization of intangible assets	333,057	325,446
Amortization of other deferred costs	100,815	61,184
Valuation adjustment for warrants liability	(31,210)	(39,403)
Share-based compensation expense	267,174	477,212
Other valuation adjustments	48,467	47,417
(Gain) loss on disposal of property and equipment	(720)	567
Provision for accounts receivable	187,134	71,907
Changes in assets and liabilities, net of effects of acquisitions:
Accounts and contract receivables	618,647	108,002
Other assets	(97,889)	(39,082)
Accounts payable	(240,403)	(567,503)
Accrued expenses	382,530	(279,881)
Deferred revenues	(1,754,246)	(2,183,705)
Net cash used in operating activities	(1,454,942)	(2,459,009)
Investing activities:
Purchases of property and equipment	(8,719)	(11,654)
Capitalization of software development costs	(386,498)	(497,988)
Net cash used in investing activities	(395,217)	(509,642)
Financing activities:
Principal repayments on term loan	(163,951)	(168,451)
Principal payments on capital lease obligation	(33,811)	(217,110)
Payments related to settlement of employee shared-based awards	(28,927)	(11,702)
Net cash used in financing activities	(226,689)	(397,263)
Net decrease in cash and cash equivalents	(2,076,848)	(3,365,914)
Cash and cash equivalents at beginning of period	5,654,093	9,882,136
Cash and cash equivalents at end of period	$ 3,577,245	$ 6,516,222